ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer

Imaging, Expert Panel on Urologic; Allen, Brian C.; Oto, Aytekin; Akın, Oğuz; Alexander, Lauren; Chong, Jaron; Froemming, Adam T.; Fulgham, Pat F.; Lloyd, Shane; Maranchie, Jodi K.; Mody, Rekha N.; Patel, Bhavik N.; Schieda, Nicola; Türkbey, İsmail Barış; Vapiwala, Neha; Venkatesan, Aradhana M.; Wang, Carolyn L.; Yoo, Don C.; Lockhart, Mark E.

doi:10.1016/j.jacr.2019.05.026

Cited by 10 publications

(10 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Restaging CT exams are generally considered appropriate for patients with NMIBC with symptoms or risk factors or MIBC following treatment courses as surveillance [22]. These can be performed as either standard contrast-enhanced CT scans or as CT urography.…”

Section: Restagingmentioning

confidence: 99%

“…These can be performed as either standard contrast-enhanced CT scans or as CT urography. Low-risk NMIBC patients do not typically require serial surveillance CT exams or routine upper tract surveillance evaluations [22]. Risk factors for NMIBC recurrence/progression include tumors ≥3 cm, multiple tumors, carcinoma in situ, known recurrence and shortened time frame for recurrence, higher tumor grade, increased tumor stage, lymphovascular invasion, prostatic urethral invasion, variant histology, and poor response to intravesical Bacillus Calmette-Guerin (BCG) immunomodulation therapy [23].…”

Section: Restagingmentioning

confidence: 99%

See 1 more Smart Citation

The Role of Imaging in Bladder Cancer Diagnosis and Staging

et al. 2020

View full text Add to dashboard Cite

Bladder cancer (BC) is the most common cancer of the urinary tract in the United States. Imaging plays a significant role in the management of patients with BC, including the locoregional staging and evaluation for distant metastatic disease, which cannot be assessed at the time of cystoscopy and biopsy/resection. We aim to review the current role of cross-sectional and molecular imaging modalities for the staging and restaging of BC and the potential advantages and limitations of each imaging modality. CT is the most widely available and frequently utilized imaging modality for BC and demonstrates good performance for the detection of nodal and visceral metastatic disease. MRI offers potential value for the locoregional staging and evaluation of muscular invasion of BC, which is critically important for prognostication and treatment decision-making. FDG-PET/MRI is a novel hybrid imaging modality combining the advantages of both MRI and FDG-PET/CT in a single-setting comprehensive staging examination and may represent the future of BC imaging evaluation.

show abstract

Section: Restagingmentioning

confidence: 99%

Section: Restagingmentioning

confidence: 99%

The Role of Imaging in Bladder Cancer Diagnosis and Staging

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Chief complaint is the haematuria, possibility of carcinoma in situ (CIS) should not be forgotten in the patients with lower urinary tract symptoms,mainly haematuria and also possibility of urothelial cancer in the upper urinary system increases in the presence of cancer in the trigone and high-risk cancers, none of the radiological imaging method is effective for the diagnosis of CIS [1,5,6]. Approximately 75% of BCs are diagnosed before muscle invasion so cystoscopy is an indispensable method in the diagnosis of papillary bladder cancers, tissue resection is required for definitive diagnosis and it is applied together with cytology and/or biopsies to prove the presence of CIS [5][6][7].…”

Section: Data Sourcesmentioning

confidence: 99%

Current CT and MRI Applications in the Diagnosis of Bladder Cancer: A Review

Aydın¹,

Bilgin²,

Özdemir³

et al. 2023

COR

View full text Add to dashboard Cite

Most common urinary system cancer is the Bladder cancer(BC), more common in men (M/F: 3), is associated with both genetic and environmental factors.,two most well-known environmental factors are smoking and occupational exposures.Smoking is associated with 25-65% of BC cases, %50 average. Urothelial cancers are common in occupations that use paint, textiles, rubber and petroleum products. Among the chemical substances; O-toluidine, 2-naphthylamine, benzidine, 4-amino-biphenyl and nitrosamines are particularly related with the BC. Our objective in this systematic review is to indicate the value and aid of CT and MRI in the diagnosis of bladder cancer.

show abstract

“…Although there are differences in the results of propensity score studies, it is inevitable that patients with eGFR<30 mL/min/1.73 m 2 have the highest risk of CI-AKI. 15 A consensus has revealed that intravenous CM exposure cannot increase the risk of CI-AKI in patients with an eGFR of 30-44 mL/min/1.73 m 2 , 15,16 but we need further research on diabetic patients.…”

Section: Epidemiologymentioning

confidence: 99%

Contrast-Associated Acute Kidney Injury: Advances and Challenges

Li¹,

Pan²

2022

IJGM

View full text Add to dashboard Cite

A decrease in renal function that follows intravascular administration of contrast medium (CM) within a few days is reported as contrast-induced acute kidney injury (CI-AKI). In clinical practice, the imaging procedure is frequently deferred when clinicians consider that the renal risks caused by CM outweigh the benefits of enhanced imaging. However, with an in-depth understanding of AKI and contrast medium, scholars have realized that the decrease in renal function after CM is caused by contrast medium factors and noncontrast medium factors (such as anemia and hemodynamic instability). Therefore, acute kidney injury caused by CM has been overestimated in the past. The term "contrast-associated acute kidney injury (CA-AKI)" has been increasingly used to indicate AKI after intravascular administration of contrast medium compared with CI-AKI. CA-AKI can increase the risk of death and chronic kidney disease. However, its pathophysiological mechanism has not been fully elucidated, and the effectiveness of various preventive and therapeutic measures have been questioned. These present challenges for us. In this article, we will review the diagnostic criteria, epidemiology, risk factors, pathophysiological mechanisms and treatment of CA-AKI to provide optimized imaging procedures in clinical practice.

show abstract

ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer

Cited by 10 publications

References 52 publications

The Role of Imaging in Bladder Cancer Diagnosis and Staging

The Role of Imaging in Bladder Cancer Diagnosis and Staging

Current CT and MRI Applications in the Diagnosis of Bladder Cancer: A Review

Contrast-Associated Acute Kidney Injury: Advances and Challenges

Contact Info

Product

Resources

About